Economic and Financial Determinants of Pharmaceutical Stock Returns: Evidence from Panel Data Analysis
Mohammadmahdi Mojahedian, Hossein Takamoli, Ahmad Ahmadi Teymourlouy, Azita Nabizadeh, Saman Zartab · 2025
Read Economic and Financial Determinants of Pharmaceutical Stock Returns: Evidence from Panel Data Analysis by Mohammadmahdi Mojahedian, Hossein Takamoli, Ahmad Ahmadi Teymourlouy, Azita Nabizadeh, Saman Zartab (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13097214.txt.
Description
Mohammadmahdi Mojahedian and co-authors test which economic and firm factors drive drug company stock returns in a 2025 study. Fundamental analysis assumes returns reflect more than the market itself, they also follow the wider economy, the industry, and each firm's own condition. The team asked how those fundamentals relate to both return and investment risk.
Financial data for twenty drug firms listed in Tehran were analyzed over a decade with panel methods. Seven variables, from cash ratio and asset turnover to debt equity ratio and inflation, explained about a quarter of same year return changes and more the next year. Six other variables, including profit margin and debt asset ratio, shaped investment risk.
Catalog record
| CREATOR | Mohammadmahdi Mojahedian, Hossein Takamoli, Ahmad Ahmadi Teymourlouy, Azita Nabizadeh, Saman Zartab |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |